| Îñîáëèâîñò³ êë³í³êè òà ôàðìàêîòåðàﳿ äåïðåñ³é ç óðàõóâàííÿì ñó÷àñíèõ ïàòîïëàñòè÷íèõ ôàêòîð³â ÎÊ Íàïðººíêî, ÂÎ Ïðîöèê Àðõ³â ïñèõ³àò𳿠10 (1), 31, 2004 | 16 | 2004 |
| Ñóèöèäàëüíûå ïðîÿâëåíèÿ ïðè ïñèõè÷åñêèõ ðàññòðîéñòâàõ ó ëèö ñòàðøå 45 ëåò ÂÀ Ïðîöûê àâòîðåô. äèñ.… ê. ì. í, 1992 | 9 | 1992 |
| Øèçîôðåí³ÿ ç ñèìïòîìàìè äåïðåñ³¿: êë³í³÷í³ ïðîÿâè òà ë³êóâàííÿ ò³îðèëîì (ò³îðèäàçèíîì) ÎÊ Íàïðººíêî, ÂÎ Ïðîöèê, ËÑ Ïàìïóõà Óêðà¿íñüêèé â³ñíèê ïñèõîíåâðîëî㳿, 90-92, 2006 | 7 | 2006 |
| Ýïèëåïòè÷åñêèé øèçîôðåíîïîäîáíûé ïñèõîç. Êëèíè÷åñêîå íàáëþäåíèå â äèíàìèêå ÀÊ Íàïðååíêî, ÂÀ Ïðîöûê, Í Øêëÿðåâñêàÿ, Å Õîìåíêî Ïñèõèàòðèÿ, ïñèõîòåðàïèÿ è êëèíè÷åñêàÿ ïñèõîëîãèÿ, 142-154, 2012 | 1 | 2012 |
| ÑÒÈÌÓËÎÒÎÍ (ÑÅÐÒÐÀËÈÍ)  ËÅ×ÅÍÈÈ ÁÎËÜÍÛÕ Ñ ÄÅÏÐÅÑÑÈÂÍÛÌÈ ÐÀÑÑÒÐÎÉÑÒÂÀÌÈ ÀÊ Íàïðååíêî, ÂÀ Ïðîöûê, ËÑ Ïàìïóõà Æóðíàë ïñèõèàòðèè è ìåäèöèíñêîé ïñèõîëîãèè, 102-105, 2023 | | 2023 |
| ÏÑÈÕÎÄÈÀÃÍÎÑÒÈÊÀ ÑÓÈÖÈÄÀ. ÃÊ Äçþá, ÂÀ ÏðîöèÊ Likarska Sprava, 2019 | | 2019 |
| Ïàòîïñèõîëîã³ÿ. Íàâ÷àëüíèé ïîñ³áíèê ÂÎÏ ².Â.Êðóê, Ã.Ê.Äçþá https://7df79adb-3552-4177-bfa2-92b59924d734.filesusr.com/ugd …, 2019 | | 2019 |
| ÀÊÒÓÀËÜÍÀ ÏÐÎÁËÅÌÀ ÃÊ Äçþá, ÂÀ ÏðîöèÊ | | 2019 |
| Øèçîôðåí³ÿ ÷è åï³ëåïòè÷íèé øèçîôðåíîïîä³áíèé ïñèõîç? Îïèñ êë³í³÷íîãî âèïàäêó ÎÊ Íàïðººíêî, ÂÎ Ïðîöèê, ÎÀ Äâ³ðñüêèé, Í Øêëÿðåâñüêà, Ê Õîìåíêî Óêðà¿íñüêèé â³ñíèê ïñèõîíåâðîëî㳿, 86-92, 2011 | | 2011 |
| STIMULOTON (SERTRALIN) IN TREATMENT OF PATIENTS WITH DEPRESSIVE DISORDERS OK Napryeyenko, VO Protsyk, LS Pampucha ÄÎÊÀÇÀÒÅËÜÍÀß ÌÅÄÈÖÈÍÀ–ÍÎÂÛÉ ÝÒÀÏ ÐÅÔÎÐÌÈÐÎÂÀÍÈß ÏÑÈÕÈÀÒÐÈÈ Â ÓÊÐÀÈÍÅ 4, 105, 2004 | | 2004 |
| The treatment of atypical manias with finlepsin-retard HK Dziub, AP Chuprykov, AS Harnyts' ka, VO Protsyk, VM Os' kina, ... Likars' ka Sprava, 146-148, 1996 | | 1996 |
| Comparison of carbamazepine and beta-endorphin levels in manic states treatment VA Procic European Neuropsychopharmacology 3 (5), 302, 1995 | | 1995 |
| Typology of suicidal behavior in the clinical picture of the principal forms of mental disorders VA Protsyk Vrachebnoe delo, 101-103, 1984 | | 1984 |
| Çàñíóâàííÿ Êè¿âñüêî¿ êë³í³÷íî¿ ïñèõ³àò𳿠ÎÊ Íàïðººíêî, ÂÎ Ïðîöèê Èñòîðèÿ óêðàèíñêîé ïñèõèàòðèè, Ñá. íàó÷íûõ ðàáîò 1, 106-108, 0 | | |
